InDevR’s automated, multiplex immunoassay solutions for vaccine testing consolidate multiple assays into a single test to significantly reduce testing times and improve overall assay sensitivity and specificity for novel vaccine development, optimization of existing formulations and production scale-up.
Simplify. Standardize. Speed Development.
Hear how Vaxess Technologies saved significant time and resources using the VaxArray Platform for novel vaccine development on their MIMIX Patch Platform.
VaxArray® CQA Test Kits
Influenza
Simplify and accelerate characterization of HA and NA antigens. Monovalent and multivalent kits for reliable subtype specific quantification of vaccines from egg- and cell-based production methods or mRNA and viral vector protein expression.
Coronavirus
Quantification of antigen or antibody response for vaccine development. Multiplex measurement of both pandemic and endemic strains of SARS-CoV-2.
Measles & Rubella
Same-day antigen quantitation. Analyze monovalent measles, monovalent rubella, or bivalent vaccine samples.
Pneumococcal
Simultaneous analysis of up to 23 polysaccharide serotypes in a single assay. Rapid and sensitive identity, quantity, and stability testing of monovalent and multivalent bioprocess samples, drug substance and drug product.
Poliovirus
Serotype specific & stability indicating poliovirus antigen quantification. Get results in as little as 1 hour.
InDevR’s Instruments and Services
